Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s disease

[1]  B. Hallgren,et al.  THE EFFECT OF AGE ON THE NON‐HAEMIN IRON IN THE HUMAN BRAIN , 1958, Journal of neurochemistry.

[2]  R. Terry,et al.  ULTRASTRUCTURAL STUDIES IN ALZHEIMER'S PRESENILE DEMENTIA. , 1964, The American journal of pathology.

[3]  N. Geschwind.  Disconnexion syndromes in animals and man. I. , 1965, Brain : a journal of neurology.

[4]  J. O'brien,et al.  Lipid composition of the normal human brain: gray matter, white matter, and myelin. , 1965, Journal of lipid research.

[5]  P. Yakovlev,et al.  The myelogenetic cycles of regional maturation of the brain , 1967 .

[6]  A. Minkowski,et al.  Regional Development of the Brain in Early Life , 1968 .

[7]  T A Sears,et al.  The effects of experimental demyelination on conduction in the central nervous system. , 1970, Brain : a journal of neurology.

[8]  A Barbeau,et al.  [Huntington's chorea: 1872-1972]. , 1972, L'union medicale du Canada.

[9]  G. Rouser,et al.  Lipids in the nervous system of different species as a function of age: brain, spinal cord, peripheral nerve, purified whole cell preparations, and subcellular particulates: regulatory mechanisms and membrane structure. , 1972, Advances in lipid research.

[10]  S G Waxman,et al.  Conduction in myelinated, unmyelinated, and demyelinated fibers. , 1977, Archives of neurology.

[11]  B Chance,et al.  Hydroperoxide metabolism in mammalian organs. , 1979, Physiological reviews.

[12]  J A Corsellis,et al.  VARIATION WITH AGE IN THE VOLUMES OF GREY AND WHITE MATTER IN THE CEREBRAL HEMISPHERES OF MAN: MEASUREMENTS WITH AN IMAGE ANALYSER , 1980, Neuropathology and applied neurobiology.

[13]  R. Thompson,et al.  The Molecular basis of neuropathology , 1981 .

[14]  A. Meyer,et al.  Paul Flechsig’s System of Myelogenetic Cortical Localization In the Light of Recent Research in Neuroanatomy and Neurophysiology Part II , 1981, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[15]  R. Wiggins.  Myelin development and nutritional insufficiency , 1982, Brain Research Reviews.

[16]  M. Moscarello,et al.  Changes in lipid phase behaviour in human myelin during maturation and aging , 1983, FEBS letters.

[17]  Richard P. Bunge,et al.  The Biology of the Oligodendrocyte , 1984 .

[18]  P. Morell,et al.  In Vivo Metabolism of Oligodendroglial Lipids , 1984 .

[19]  J. Thompson,et al.  X-ray diffraction evidence for myelin disorder in brain from humans with Alzheimer's disease. , 1984, Biochimica et biophysica acta.

[20]  M. Malone,et al.  Neurochemical changes in white matter. Aged human brain and Alzheimer's disease. , 1985, Archives of neurology.

[21]  Gary Aston-Jones,et al.  Age-impaired impulse flow from nucleus basalis to cortex , 1985, Nature.

[22]  P. Yeagle.  Cholesterol and the cell membrane. , 1985, Biochimica et biophysica acta.

[23]  R. Epand,et al.  Modulation of myelin basic protein-induced aggregation and fusion of liposomes by cholesterol, aliphatic aldehydes and alkanes. , 1986, Biochimica et biophysica acta.

[24]  A. Brun,et al.  A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study , 1986, Annals of neurology.

[25]  B. Halliwell,et al.  Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. , 1986, Archives of biochemistry and biophysics.

[26]  P. Goldman-Rakic,et al.  Concurrent overproduction of synapses in diverse regions of the primate cerebral cortex. , 1986, Science.

[27]  V. Swayze,et al.  Two Hemispheres—One Brain: Functions of the Corpus Callosum , 1987 .

[28]  B. Brody,et al.  Sequence of Central Nervous System Myelination in Human Infancy. I. An Autopsy Study of Myelination , 1987, Journal of neuropathology and experimental neurology.

[29]  A Brun,et al.  White matter changes in dementia of Alzheimer's type. Biochemical and neuropathological correlates. , 1988, Brain : a journal of neurology.

[30]  R. Mahley,et al.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.

[31]  H. Kinney,et al.  Sequence of Central Nervous System Myelination in Human Infancy. II. Patterns of Myelination in Autopsied Infants , 1988, Journal of neuropathology and experimental neurology.

[32]  S. Monte.  Disproportionate Atrophy of Cerebral White Matter in Chronic Alcoholics , 1988 .

[33]  J. Growdon,et al.  Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease , 1989, Annals of neurology.

[34]  S. M. Sumi,et al.  Phenotypic heterogeneity in familial alzheimer's disease: A study of 24 kindreds , 1989, Annals of neurology.

[35]  A. Wallin,et al.  Decreased myelin lipids in Alzheimer's disease and vascular dementia , 1989, Acta neurologica Scandinavica.

[36]  S. M. de la Monte,et al.  Quantitation of cerebral atrophy in preclinical and end‐stage alzheimer's disease , 1989, Annals of neurology.

[37]  J. Morrison,et al.  Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: II. Primary and secondary visual cortex , 1990, The Journal of comparative neurology.

[38]  M M Mesulam,et al.  Large‐scale neurocognitive networks and distributed processing for attention, language, and memory , 1990, Annals of neurology.

[39]  P. Rakić,et al.  Cytological and quantitative characteristics of four cerebral commissures in the rhesus monkey , 1990, The Journal of comparative neurology.

[40]  Kevin Cox,et al.  Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex , 1990, The Journal of comparative neurology.

[41]  D. McLachlan,et al.  Intramuscular desferrioxamine in patients with Alzheimer's disease , 1991, The Lancet.

[42]  W. Markesbery,et al.  Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Peter Davies,et al.  Identification of normal and pathological aging in prospectively studied nondemented elderly humans , 1992, Neurobiology of Aging.

[44]  C. Morris,et al.  Histochemical distribution of non-haem iron in the human brain. , 1992, Acta anatomica.

[45]  L. Herbette,et al.  Evidence for changes in the Alzheimer's disease brain cortical membrane structure mediated by cholesterol , 1992, Neurobiology of Aging.

[46]  W. Meier-Ruge,et al.  Age‐Related White Matter Atrophy in the Human Brain , 1992, Annals of the New York Academy of Sciences.

[47]  A. Hofman,et al.  Epidemiology of Alzheimer's disease. , 1992, Epidemiologic reviews.

[48]  H. Persson,et al.  Myelinated nerve fibres in the CNS , 1993, Progress in Neurobiology.

[49]  R. Floyd,et al.  The Role of Metal Ions in Oxidative Processes and Aging , 1993, Toxicology and industrial health.

[50]  P. Mecocci,et al.  Oxidative damage to mitochondrial DNA shows marked age‐dependent increases in human brain , 1993, Annals of neurology.

[51]  L. Ignarro,et al.  Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. , 1993, Journal of immunology.

[52]  M. Albert,et al.  Neuropsychological and neurophysiological changes in healthy adult humans across the age range , 1993, Neurobiology of Aging.

[53]  A. L. Watson,et al.  In vitro polymerization of oxidized tau into filaments , 1993, Brain Research.

[54]  M. Carson,et al.  Insulin-like growth factor I increases brain growth and central nervous system myelination in tTransgenic mice , 1993, Neuron.

[55]  T. Kemper,et al.  Neuroanatomical and neuropathological changes during aging and dementia. , 1994 .

[56]  B. Pakkenberg,et al.  No global neocortical nerve cell loss in brains from patients with senile dementia of Alzheimer's type , 1994, Neurobiology of Aging.

[57]  E. Änggård.  Nitric oxide: mediator, murderer, and medicine , 1994, The Lancet.

[58]  G. Bartzokis,et al.  In vivo MR evaluation of age-related increases in brain iron. , 1994, AJNR. American journal of neuroradiology.

[59]  C. Gottfries,et al.  Membrane Lipids, Selectively Diminished in Alzheimer Brains, Suggest Synapse Loss as a Primary Event in Early‐Onset Form (Type I) and Demyelination in Late‐Onset Form (Type II) , 1994, Journal of neurochemistry.

[60]  J. Troncoso,et al.  Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease , 1994, The Lancet.

[61]  Jim Mintz,et al.  In vivo evaluation of brain iron in Alzheimer's disease and normal subjects using MRI , 1994, Biological Psychiatry.

[62]  F. Benes,et al.  Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood, adolescence, and adulthood. , 1994, Archives of general psychiatry.

[63]  B. Juurlink,et al.  Oligodendroglial precursor cell susceptibility to hypoxia is related to poor ability to cope with reactive oxygen species , 1995, Brain Research.

[64]  W. D. Ehmann,et al.  Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease , 1995, Neurology.

[65]  F. Schroeder,et al.  Cholesterol domains in biological membranes. , 1995, Molecular membrane biology.

[66]  R. S. Sohal,et al.  Mitochondrial superoxide and hydrogen peroxide generation, protein oxidative damage, and longevity in different species of flies. , 1995, Free radical biology & medicine.

[67]  J. Assouline,et al.  Electrically evoked auditory brainstem response in peripherally myelin-deficient mice , 1995, Hearing Research.

[68]  H. Vinters,et al.  Nitric oxide induces necrotic but not apoptotic cell death in oligodendrocytes , 1995, Neuroscience.

[69]  H. Braak,et al.  Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes , 1995, Neuroscience.

[70]  S. LeVine,et al.  The distribution of iron in the brain: a phylogenetic analysis using iron histochemistry. , 1996, Brain research. Developmental brain research.

[71]  J. Connor,et al.  The expression of ferritin subunits and iron in oligodendrocytes in neonatal porcine brains. , 1996, Developmental neuroscience.

[72]  D. Perl,et al.  Evidence of neuronal oxidative damage in Alzheimer's disease. , 1996, The American journal of pathology.

[73]  V Hachinski,et al.  Diffuse vacuolization (spongiosis) and arteriolosclerosis in the frontal white matter occurs in vascular dementia. , 1996, Archives of neurology.

[74]  Rita Y. Emmerson,et al.  Life Span Changes in Electrophysiological Measures of Inhibition , 1996, Brain and Cognition.

[75]  C. Gottfries,et al.  Membrane Components Separate Early-Onset Alzheimer's Disease From Senile Dementia of the Alzheimer Type , 1996, International Psychogeriatrics.

[76]  J. Connor,et al.  Relationship of iron to oligondendrocytes and myelination , 1996 .

[77]  D. Salmon,et al.  Association of dementia severity with cortical gray matter and abnormal white matter volumes in dementia of the Alzheimer type. , 1996, Archives of neurology.

[78]  C. Morris,et al.  Ascorbate promotes low density lipoprotein oxidation in the presence of ferritin. , 1996, Biochimica et biophysica acta.

[79]  B. Pakkenberg,et al.  Age-Induced White Matter Changes in the Human Brain: A Stereological Investigation , 1997, Neurobiology of Aging.

[80]  C. Cotman,et al.  β‐Amyloid Neurotoxicity In Vitro: Evidence of Oxidative Stress but Not Protection by Antioxidants , 1997, Journal of neurochemistry.

[81]  J. Garcìa,et al.  Pathogenesis of leukoaraiosis: a review. , 1997, Stroke.

[82]  G. Bartzokis,et al.  MR evaluation of age-related increase of brain iron in young adult and older normal males. , 1997, Magnetic resonance imaging.

[83]  U. Igbavboa,et al.  Lipid Binding to Amyloid β‐Peptide Aggregates: Preferential Binding of Cholesterol as Compared with Phosphatidylcholine and Fatty Acids , 1997, Journal of neurochemistry.

[84]  Kenneth J. Smith,et al.  Conduction in Segmentally Demyelinated Mammalian Central Axons , 1997, The Journal of Neuroscience.

[85]  M. Ghandour,et al.  Oligodendrocytes express different isoforms of β‐amyloid precursor protein in chemically defined cell culture conditions: In situ hybridization and immunocytochemical detection , 1997, Journal of neuroscience research.

[86]  B. Juurlink.  Response of Glial Cells to Ischemia: Roles of Reactive Oxygen Species and Glutathione , 1997, Neuroscience & Biobehavioral Reviews.

[87]  R. Miledi,et al.  Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[88]  H. Braak,et al.  Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories , 1997, Neurobiology of Aging.

[89]  D. Hanger,et al.  Oxidative Stress Induces Dephosphorylation of τ in Rat Brain Primary Neuronal Cultures , 1997 .

[90]  M Takasaki,et al.  Increased water diffusion in cerebral white matter in Alzheimer's disease. , 1997, Gerontology.

[91]  P. Huttenlocher,et al.  Regional differences in synaptogenesis in human cerebral cortex , 1997, The Journal of comparative neurology.

[92]  U. Igbavboa,et al.  Transbilayer Distribution of Cholesterol Is Modified in Brain Synaptic Plasma Membranes of Knockout Mice Deficient in the Low‐Density Lipoprotein Receptor, Apolipoprotein E, or Both Proteins , 1997, Journal of neurochemistry.

[93]  W R Markesbery,et al.  Oxidative stress hypothesis in Alzheimer's disease. , 1997, Free radical biology & medicine.

[94]  A. Bosio,et al.  Myelin glycolipids and their functions , 1997, Current Opinion in Neurobiology.

[95]  G. Bartzokis,et al.  Relationship between blood pressure and subcortical lesions in healthy elderly people. , 1998, Stroke.

[96]  R. Kikinis,et al.  White matter changes with normal aging , 1998, Neurology.

[97]  S. Cadenas,et al.  The rate of free radical production as a determinant of the rate of aging: evidence from the comparative approach , 1998, Journal of Comparative Physiology B.

[98]  M. Garrido,et al.  Evidence of altered central nervous system development in infants with iron deficiency anemia at 6 mo: delayed maturation of auditory brainstem responses. , 1998, The American journal of clinical nutrition.

[99]  T. Kachi,et al.  Auditory and visual event-related potentials and flash visual evoked potentials in Alzheimer's disease: correlations with Mini-Mental State Examination and Raven's Coloured Progressive Matrices , 1998, Journal of the Neurological Sciences.

[100]  Reinhold Schmidt,et al.  Pathophysiologic Mechanisms in the Development of Age-Related White Matter Changes of the Brain , 1998, Dementia and Geriatric Cognitive Disorders.

[101]  Xudong Huang,et al.  Dramatic Aggregation of Alzheimer Aβ by Cu(II) Is Induced by Conditions Representing Physiological Acidosis* , 1998, The Journal of Biological Chemistry.

[102]  Joseph J. Volpe,et al.  Maturation-Dependent Vulnerability of Oligodendrocytes to Oxidative Stress-Induced Death Caused by Glutathione Depletion , 1998, The Journal of Neuroscience.

[103]  T. Kudo,et al.  White matter changes in the gerbil brain under chronic cerebral hypoperfusion. , 1998, Stroke.

[104]  P. Riederer,et al.  In Vitro Studies of Ferritin Iron Release and Neurotoxicity , 1998, Journal of neurochemistry.

[105]  J. Mcdonald,et al.  Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity , 1998, Nature Medicine.

[106]  S. Bondy,et al.  Promotion of transition metal-induced reactive oxygen species formation by β-amyloid , 1998, Brain Research.

[107]  J. Connor,et al.  Abnormal localization of iron regulatory protein in Alzheimer's disease , 1998, Brain Research.

[108]  P. Davidson,et al.  Prenatal methylmercury exposure and children: neurologic, developmental, and behavioral research. , 1998, Environmental health perspectives.

[109]  F Lepore,et al.  Interhemispheric disconnection syndrome in Alzheimer's disease. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[110]  Bruce A. Yankner,et al.  Aging renders the brain vulnerable to amyloid β-protein neurotoxicity , 1998, Nature Medicine.

[111]  M N Rossor,et al.  Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer's disease. A longitudinal prospective study. , 1998, Brain : a journal of neurology.

[112]  R. Nieuwenhuys,et al.  The Central Nervous System of Vertebrates , 1997, Springer Berlin Heidelberg.

[113]  M. Beal,et al.  The neurotoxicity of amyloid beta protein in aged primates. , 1998, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[114]  O. Salonen,et al.  Gelsolin‐related spinal and cerebral amyloid angiopathy , 1999, Annals of neurology.

[115]  K. Berman,et al.  Context-dependent, neural system-specific neurophysiological concomitants of ageing: mapping PET correlates during cognitive activation. , 1999, Brain : a journal of neurology.

[116]  J. Wettstein,et al.  White matter ischaemia , 1999, Brain Research Reviews.

[117]  J. Trojanowski,et al.  The Levels of Soluble versus Insoluble Brain Aβ Distinguish Alzheimer's Disease from Normal and Pathologic Aging , 1999, Experimental Neurology.

[118]  M. Berry,et al.  In vivo actions of fibroblast growth factor‐2 and insulin‐like growth factor‐I on oligodendrocyte development and myelination in the central nervous system , 1999, Journal of neuroscience research.

[119]  C. Haass,et al.  Cholesterol-dependent Generation of a Seeding Amyloid β-Protein in Cell Culture* , 1999, The Journal of Biological Chemistry.

[120]  C. Glabe,et al.  Binding of Zn(II), Cu(II), and Fe(II) ions to Alzheimer's A beta peptide studied by fluorescence. , 1999, Bioorganic & medicinal chemistry letters.

[121]  T. Crow,et al.  Fiber content of the fornix in schizophrenia: lack of evidence for a primary limbic encephalopathy. , 1999, The American journal of psychiatry.

[122]  E. Gould,et al.  Learning enhances adult neurogenesis in the hippocampal formation , 1999, Nature Neuroscience.

[123]  P. Hof,et al.  Preservation of Prefrontal Cortical Volume in Behaviorally Characterized Aged Macaque Monkeys , 1999, Experimental Neurology.

[124]  J M Fuster,et al.  Synopsis of function and dysfunction of the frontal lobe , 1999, Acta psychiatrica Scandinavica. Supplementum.

[125]  S. Bondy,et al.  The stabilization of ferrous iron by a toxic β-amyloid fragment and by an aluminum salt , 1999, Brain Research.

[126]  U. Igbavboa,et al.  Recent advances in brain cholesterol dynamics: Transport, domains, and Alzheimer's disease , 1999, Lipids.

[127]  A. Rodríguez-Peña,et al.  Oligodendrocyte development and thyroid hormone. , 1999, Journal of neurobiology.

[128]  W R Markesbery,et al.  The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients. , 1999, The American journal of pathology.

[129]  Sarah Tomlin,et al.  Microtechnology: Laying it on thick , 1999, Nature.

[130]  Ramesh Srinivasan,et al.  Spatial structure of the human alpha rhythm: global correlation in adults and local correlation in children , 1999, Clinical Neurophysiology.

[131]  J. Sloane,et al.  Increased microglial activation and protein nitration in white matter of the aging monkey☆ , 1999, Neurobiology of Aging.

[132]  M. Xi,et al.  Changes in the axonal conduction velocity of pyramidal tract neurons in the aged cat , 1999, Neuroscience.

[133]  G. Bartzokis,et al.  Magnetic resonance imaging evidence of “silent” cerebrovascular toxicity in cocaine dependence , 1999, Biological Psychiatry.

[134]  H. Braak,et al.  Temporal Sequence of Alzheimer’s Disease-Related Pathology , 1999 .

[135]  D. Selkoe,et al.  Translating cell biology into therapeutic advances in Alzheimer's disease , 1999, Nature.

[136]  H. Braak,et al.  Age-related progression of tau pathology in brains of baboons , 2000, Neurobiology of Aging.

[137]  Alan Peters,et al.  The effects of aging on the frequency of nerve fibers in rhesus monkey striate cortex , 2000, Neurobiology of Aging.

[138]  A. Fagan,et al.  Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[139]  M. Mesulam,et al.  A Plasticity‐Based Theory of the Pathogenesis of Alzheimer's Disease , 2000, Annals of the New York Academy of Sciences.

[140]  G. Bartzokis,et al.  In vivo evaluation of brain iron in Alzheimer disease using magnetic resonance imaging. , 2000, Archives of general psychiatry.

[141]  H. Braak,et al.  Sequence of Aβ‐Protein Deposition in the Human Medial Temporal Lobe , 2000 .

[142]  J. de Vellis,et al.  Dietary iron and the integrity of the developing rat brain: a study with the artificially-reared rat pup. , 2000, Cellular and molecular biology.

[143]  C. Cotman,et al.  Ultrastructural analyses of β-amyloid in the aged dog brain: Neuronal β-amyloid is localized to the plasma membrane , 2000, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[144]  J. Mazziotta,et al.  Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[145]  Xudong Huang,et al.  Evidence that the β-Amyloid Plaques of Alzheimer's Disease Represent the Redox-silencing and Entombment of Aβ by Zinc* , 2000, The Journal of Biological Chemistry.

[146]  A. D'ercole,et al.  Insulin‐like growth factor‐I (IGF‐I) protects myelination from undernutritional insult: Studies of transgenic mice overexpressing IGF‐I in brain , 2000, Journal of neuroscience research.

[147]  S. Carlton,et al.  Peripheral glutamate release in the hindpaw following low and high intensity sciatic stimulation , 2000, Neuroreport.

[148]  P. Ye,et al.  Insulin-Like Growth Factor-1 Inhibits Mature Oligodendrocyte Apoptosis during Primary Demyelination , 2000, The Journal of Neuroscience.

[149]  J. Sastre,et al.  Mitochondria, oxidative stress and aging , 2000, Free radical research.

[150]  V. Challa,et al.  Cerebrovascular Pathology in Alzheimer's Disease and Leukoaraiosis , 2000, Annals of the New York Academy of Sciences.

[151]  V. Papadopoulos,et al.  Pathways of Neurosteroid Biosynthesis in Cell Lines from Human Brain , 2000, Journal of neurochemistry.

[152]  M. Smith,et al.  Oxidative stress in Alzheimer's disease. , 2000, Biochimica et biophysica acta.

[153]  Alan C. Evans,et al.  Growth patterns in the developing brain detected by using continuum mechanical tensor maps , 2000, Nature.

[154]  P. Riederer,et al.  Transition metal-mediated glycoxidation accelerates cross-linking of beta-amyloid peptide. , 2000, European journal of biochemistry.

[155]  H. Braak,et al.  Filamentous Tau Pathology in Nerve Cells, Astrocytes, and Oligodendrocytes of Aged Baboons , 2000, Journal of neuropathology and experimental neurology.

[156]  Alan Peters,et al.  Effects of aging on myelinated nerve fibers in monkey primary visual cortex , 2000, The Journal of comparative neurology.

[157]  J. Townsend,et al.  Normal brain development and aging: quantitative analysis at in vivo MR imaging in healthy volunteers. , 2000, Radiology.

[158]  L. Schmued,et al.  Temporal progression of kainic acid induced neuronal and myelin degeneration in the rat forebrain , 2000, Brain Research.

[159]  A. Bush,et al.  Oxidative processes in Alzheimer's disease: the role of Aβ-metal interactions , 2000, Experimental Gerontology.

[160]  K. Bedi,et al.  Exposure of rats to a high but not low dose of ethanol during early postnatal life increases the rate of loss of optic nerve axons and decreases the rate of myelination , 2000, Journal of anatomy.

[161]  G. Alonso.  Prolonged corticosterone treatment of adult rats inhibits the proliferation of oligodendrocyte progenitors present throughout white and gray matter regions of the brain , 2000, Glia.

[162]  J. Kuret,et al.  Oxidative regulation of fatty acid-induced tau polymerization. , 2000, Biochemistry.

[163]  Xudong Huang,et al.  Metal Chelation as a Potential Therapy for Alzheimer's Disease , 2000, Annals of the New York Academy of Sciences.

[164]  D. Butterfield,et al.  Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. , 2000, Journal of structural biology.

[165]  A. McKee,et al.  Serum amyloid A in Alzheimer's disease brain is predominantly localized to myelin sheaths and axonal membrane , 2000, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[166]  T. Miyaoka,et al.  Dementia of Alzheimer type with and without multiple lacunar infarctions: Evaluation of white matter lesions , 2000, Neuropathology : official journal of the Japanese Society of Neuropathology.

[167]  H. Braak,et al.  Vulnerability of Select Neuronal Types to Alzheimer's Disease , 2000, Annals of the New York Academy of Sciences.

[168]  R. McKinnon,et al.  Lead exposure delays the differentiation of oligodendroglial progenitors in vitro. , 2001, Toxicology and applied pharmacology.

[169]  C. Dreyfus,et al.  Neuronal signals regulate neurotrophin expression in oligodendrocytes of the basal forebrain , 2001, Glia.

[170]  E. Baulieu,et al.  Neurosteroids: recent findings , 2001, Brain Research Reviews.

[171]  W. Singer,et al.  Dynamic predictions: Oscillations and synchrony in top–down processing , 2001, Nature Reviews Neuroscience.

[172]  D. Davies,et al.  Neurodegenerative Changes Associated with β-Amyloid Deposition in the Brains of Mice Carrying Mutant Amyloid Precursor Protein and Mutant Presenilin-1 Transgenes , 2001, Experimental Neurology.

[173]  C. Palmer,et al.  Hypoxic/ischemic insult alters ferritin expression and myelination in neonatal rat brains , 2001 .

[174]  D. Burn,et al.  Multiple system atrophy: cellular and molecular pathology , 2001, Molecular pathology : MP.

[175]  D. Allsop,et al.  New evidence that the Alzheimer beta-amyloid peptide does not spontaneously form free radicals: an ESR study using a series of spin-traps. , 2001, Free radical biology & medicine.

[176]  G. Annoni,et al.  The hemochromatosis gene affects the age of onset of sporadic Alzheimer’s disease , 2001, Neurobiology of Aging.

[177]  J. Dietschy,et al.  Cholesterol metabolism in the brain , 2001, Current opinion in lipidology.

[178]  H. Braak,et al.  Gender and age modify the association between APOE and AD-related neuropathology , 2001, Neurology.

[179]  Development: Ear see rescue , 2001, Nature Reviews Neuroscience.

[180]  C. Masters,et al.  Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice , 2001, Neuron.

[181]  M. J. Wade,et al.  Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease. , 2001, Archives of neurology.

[182]  Ashley I. Bush,et al.  Redox-active iron mediates amyloid-β toxicity , 2001 .

[183]  D. Sparks,et al.  Cholesterol Accumulates in Senile Plaques of Alzheimer Disease Patients and in Transgenic APPsw Mice , 2001, Journal of neuropathology and experimental neurology.

[184]  D. Selkoe.  Alzheimer's disease: genes, proteins, and therapy. , 2001, Physiological reviews.

[185]  S. Dunlop,et al.  Repeated prenatal corticosteroid administration delays myelination of the corpus callosum in fetal sheep , 2001, International Journal of Developmental Neuroscience.

[186]  C. Masters,et al.  Alzheimer's Disease Amyloid-β Binds Copper and Zinc to Generate an Allosterically Ordered Membrane-penetrating Structure Containing Superoxide Dismutase-like Subunits* , 2001, The Journal of Biological Chemistry.

[187]  M. Goldberg,et al.  Amyloid-β Peptides Are Cytotoxic to Oligodendrocytes , 2001, The Journal of Neuroscience.

[188]  J. López.  Neurodegenerative disorders: A-beta, tau and the fabrication of tangles , 2001, Nature Reviews Neuroscience.

[189]  W. Schlote,et al.  Giant cell arteritis in a 19-year-old woman associated with vertebral artery aneurysm and subarachnoid hemorrhage. , 2001, Clinical neuropathology.

[190]  J. Martinerie,et al.  The brainweb: Phase synchronization and large-scale integration , 2001, Nature Reviews Neuroscience.

[191]  G. Bartzokis,et al.  Age-related changes in frontal and temporal lobe volumes in men: a magnetic resonance imaging study. , 2001, Archives of general psychiatry.

[192]  B. Winblad,et al.  Alzheimer's disease : advances in etiology, pathogenesis, and therapeutics , 2001 .

[193]  K. Jellinger,et al.  Problems of cell death in neurodegeneration and Alzheimer's Disease. , 2001, Journal of Alzheimer's disease : JAD.

[194]  J. Marx.  Bad for the Heart, Bad For the Mind? , 2001, Science.

[195]  O. Bertrand,et al.  Oscillatory Synchrony between Human Extrastriate Areas during Visual Short-Term Memory Maintenance , 2001, The Journal of Neuroscience.

[196]  D. Morath,et al.  Iron modulates the differentiation of a distinct population of glial precursor cells into oligodendrocytes. , 2001, Developmental biology.

[197]  B. Winblad,et al.  On the turnover of brain cholesterol in patients with Alzheimer's disease. Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells , 2001, Neuroscience Letters.

[198]  C. Elger,et al.  Human memory formation is accompanied by rhinal–hippocampal coupling and decoupling , 2001, Nature Neuroscience.

[199]  T. Ueda,et al.  The relationship between the aggregational state of the amyloid‐β peptides and free radical generation by the peptides , 2001, Journal of neurochemistry.

[200]  R. Scott,et al.  Is hemochromatosis a risk factor for Alzheimer's disease? , 2001, Journal of Alzheimer's disease : JAD.

[201]  G Ratcliff,et al.  Patterns of cognitive decline in presymptomatic Alzheimer disease: a prospective community study. , 2001, Archives of general psychiatry.

[202]  Gert Lubec,et al.  Decreased brain levels of 2′,3′-cyclic nucleotide-3′-phosphodiesterase in Down syndrome and Alzheimer’s disease , 2001, Neurobiology of Aging.

[203]  C. Göritz,et al.  CNS synaptogenesis promoted by glia-derived cholesterol. , 2001, Science.

[204]  M. O’Sullivan,et al.  Incidence of ALS in Italy , 2001, Neurology.

[205]  A Compston,et al.  A role for oligodendrocyte‐derived IGF‐1 in trophic support of cortical neurons , 2001, Glia.

[206]  U. Beisiegel,et al.  Reduction of plasma 24S-hydroxycholesterol (cerebrosterol) levels using high-dosage simvastatin in patients with hypercholesterolemia: evidence that simvastatin affects cholesterol metabolism in the human brain. , 2002, Archives of neurology.

[207]  C. Masters,et al.  Overexpression of Alzheimer's Disease Amyloid-β Opposes the Age-dependent Elevations of Brain Copper and Iron* , 2002, The Journal of Biological Chemistry.

[208]  George Bartzokis,et al.  Ambulatory blood pressure and brain atrophy in the healthy elderly , 2002, Neurology.

[209]  HR Waterham,et al.  Inherited disorders of cholesterol biosynthesis , 2002, Clinical genetics.

[210]  Arto Mannermaa,et al.  Apolipoprotein E 4 Allele, Elevated Midlife Total Cholesterol Level, and High Midlife Systolic Blood Pressure Are Independent Risk Factors for Late-Life Alzheimer Disease , 2002, Annals of Internal Medicine.

[211]  G. Kress,et al.  The Relationship between Intracellular Free Iron and Cell Injury in Cultured Neurons, Astrocytes, and Oligodendrocytes , 2002, The Journal of Neuroscience.

[212]  H. Hayashi,et al.  Cholesterol is increased in the exofacial leaflet of synaptic plasma membranes of human apolipoprotein E4 knock-in mice , 2002, Neuroreport.

[213]  T. Iwamoto,et al.  Demonstration and distribution of tau‐positive glial coiled body‐like structures in white matter and white matter threads in early onset Alzheimer’s disease , 2002, Neuropathology : official journal of the Japanese Society of Neuropathology.

[214]  J. Trojanowski,et al.  Repetitive Mild Brain Trauma Accelerates Aβ Deposition, Lipid Peroxidation, and Cognitive Impairment in a Transgenic Mouse Model of Alzheimer Amyloidosis , 2002, The Journal of Neuroscience.

[215]  J. Babb,et al.  Age-related total gray matter and white matter changes in normal adult brain. Part I: volumetric MR imaging analysis. , 2002, AJNR. American journal of neuroradiology.

[216]  Yu-Min Kuo,et al.  Increased Aβ Peptides and Reduced Cholesterol and Myelin Proteins Characterize White Matter Degeneration in Alzheimer's Disease† , 2002 .

[217]  Alan Peters,et al.  Aging and the myelinated fibers in prefrontal cortex and corpus callosum of the monkey , 2002, The Journal of comparative neurology.

[218]  V. Papadopoulos,et al.  Function of β‐amyloid in cholesterol transport: a lead to neurotoxicity , 2002 .

[219]  R. Mayeux,et al.  The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function , 2002, Neurology.

[220]  H. Braak,et al.  Phases of Aβ-deposition in the human brain and its relevance for the development of AD , 2002, Neurology.

[221]  P. Zandi,et al.  Reduced incidence of AD with NSAID but not H2 receptor antagonists: The Cache County Study , 2002, Neurology.

[222]  B. Winblad,et al.  Statins in the Prevention and Treatment of Alzheimer Disease , 2002, Alzheimer disease and associated disorders.

[223]  W. K. Cullen,et al.  Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.

[224]  D. Schenk.  Amyloid-β immunotherapy for Alzheimer's disease: the end of the beginning , 2002, Nature Reviews Neuroscience.

[225]  H. Bratzke,et al.  Incidence of axonal injury in human brain tissue , 2002, Acta Neuropathologica.

[226]  Jaakko Tuomilehto,et al.  The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. , 2002 .

[227]  Y. Koshino,et al.  Apoptosis of astrocytes with enhanced lysosomal activity and oligodendrocytes in white matter lesions in Alzheimer's disease , 2002, Neuropathology and applied neurobiology.

[228]  K. Heilman,et al.  Relative Frequencies of Alzheimer Disease, Lewy Body, Vascular and Frontotemporal Dementia, and Hippocampal Sclerosis in the State of Florida Brain Bank , 2002, Alzheimer disease and associated disorders.

[229]  J. Joseph,et al.  Amyloid-β and τ serve antioxidant functions in the aging and Alzheimer brain , 2002 .

[230]  S. Wisniewski,et al.  Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment , 2002, Annals of neurology.

[231]  D. Okonkwo,et al.  Caspase-3-mediated cleavage of amyloid precursor protein and formation of amyloid Beta peptide in traumatic axonal injury. , 2002, Journal of neurotrauma.

[232]  H. Lassmann,et al.  Endoplasmic Reticulum Stress in PLP‐Overexpressing Transgenic Rats: Gray Matter Oligodendrocytes Are More Vulnerable than White Matter Oligodendrocytes , 2002, Journal of neuropathology and experimental neurology.

[233]  D. Allsop,et al.  Formation of hydrogen peroxide and hydroxyl radicals from Aβ and α-synuclein as a possible mechanism of cell death in Alzheimer’s disease and Parkinson’s disease. , 2002 .

[234]  M. Noble,et al.  Oligodendrocyte precursor cells from different brain regions express divergent properties consistent with the differing time courses of myelination in these regions. , 2002, Developmental biology.

[235]  H. Fillit.  The role of hormone replacement therapy in the prevention of Alzheimer disease. , 2002, Archives of internal medicine.

[236]  B. Wolozin,et al.  Cholesterol and Alzheimer's disease. , 2002, Biochemical Society transactions.

[237]  K. Zou,et al.  Cholesterol‐dependent modulation of dendrite outgrowth 
and microtubule stability in cultured neurons , 2002, Journal of neurochemistry.

[238]  F. Jessen,et al.  24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia. , 2002, Journal of psychiatric research.

[239]  J. Trojanowski,et al.  Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease. , 2002, Archives of neurology.

[240]  W. M. van der Flier,et al.  Magnetization transfer imaging in normal aging, mild cognitive impairment, and Alzheimer's disease , 2002, Annals of neurology.

[241]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[242]  U. Igbavboa,et al.  Brain membrane cholesterol domains, aging and amyloid beta-peptides , 2002, Neurobiology of Aging.

[243]  Epidemiology of Dementia in Down's Syndrome , 2002 .

[244]  G. Ojemann,et al.  Anatomic subdivisions in human temporal cortical neuronal activity related to recent verbal memory , 2002, Nature Neuroscience.

[245]  F. Craik,et al.  Lapses of Intention and Performance Variability Reveal Age-Related Increases in Fluctuations of Executive Control , 2002, Brain and Cognition.

[246]  H. Damasio,et al.  Humans and great apes share a large frontal cortex , 2002, Nature Neuroscience.

[247]  K. Zou,et al.  A Novel Function of Monomeric Amyloid β-Protein Serving as an Antioxidant Molecule against Metal-Induced Oxidative Damage , 2002, The Journal of Neuroscience.

[248]  Jim Mintz,et al.  Brain maturation may be arrested in chronic cocaine addicts , 2002, Biological Psychiatry.

[249]  Lars-Olof Wahlund,et al.  Postmortem MRI and Histopathology of White Matter Changes in Alzheimer Brains , 2002, Dementia and Geriatric Cognitive Disorders.

[250]  J. Schulz,et al.  Overexpression of the myelin proteolipid protein leads to accumulation of cholesterol and proteolipid protein in endosomes/lysosomes , 2002, The Journal of cell biology.

[251]  N. Greig,et al.  Alzheimer’s disease drug discovery targeted to the APP mRNA 5′Untranslated region , 2002, Journal of Molecular Neuroscience.

[252]  C. Yip,et al.  Aβ42-Peptide Assembly on Lipid Bilayers , 2002 .

[253]  Á. Pascual-Leone,et al.  Effects of Early Undernutrition on the Brain Insulin‐Like Growth Factor‐I System , 2002, Journal of neuroendocrinology.

[254]  Yulin Ge,et al.  Age-related total gray matter and white matter changes in normal adult brain. Part II: quantitative magnetization transfer ratio histogram analysis. , 2002, AJNR. American journal of neuroradiology.

[255]  B. Ames,et al.  Iron deficiency and iron excess damage mitochondria and mitochondrial DNA in rats , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[256]  Xianlin Han,et al.  Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis , 2002, Journal of neurochemistry.

[257]  George Bartzokis,et al.  Schizophrenia: Breakdown in the Well-regulated Lifelong Process of Brain Development and Maturation , 2002, Neuropsychopharmacology.

[258]  C. Haass,et al.  Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts , 2003, The Journal of cell biology.

[259]  H. Braak,et al.  Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism. , 2003, Archives of neurology.

[260]  B. Pakkenberg,et al.  Aging and the human neocortex , 2003, Experimental Gerontology.

[261]  G. Bartzokis,et al.  White matter structural integrity in healthy aging adults and patients with Alzheimer disease: a magnetic resonance imaging study. , 2003, Archives of neurology.

[262]  Pamela L. Follett,et al.  Mature myelin basic protein‐expressing oligodendrocytes are insensitive to kainate toxicity , 2003, Journal of neuroscience research.

[263]  Suzanne E. Welcome,et al.  Mapping cortical change across the human life span , 2003, Nature Neuroscience.

[264]  Colin J Barrow,et al.  Cholesterol is necessary both for the toxic effect of Aβ peptides on vascular smooth muscle cells and for Aβ binding to vascular smooth muscle cell membranes , 2003, Journal of neurochemistry.

[265]  G. Eckert,et al.  Statin effects on cholesterol micro-domains in brain plasma membranes. , 2003, Biochemical pharmacology.

[266]  I. Mackenzie.  Senile plaques do not progressively accumulate with normal aging , 2004, Acta Neuropathologica.

[267]  G. Bartzokis,et al.  Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical “disconnection” in aging and Alzheimer’s disease , 2004, Neurobiology of Aging.

[268]  George Bartzokis,et al.  Quadratic trajectories of brain myelin content: unifying construct for neuropsychiatric disorders , 2004, Neurobiology of Aging.

[269]  H. Wiśniewski,et al.  Spectrum of morphological appearance of amyloid deposits in Alzheimer's disease , 2004, Acta Neuropathologica.

[270]  G. Rouser,et al.  Curvilinear regression course of human brain lipid composition changes with age , 1968, Lipids.

[271]  P. Morell,et al.  Origin of cholesterol in myelin , 1996, Neurochemical Research.